These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33940011)

  • 1. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.
    Schlag AK; O'Sullivan SE; Zafar RR; Nutt DJ
    Neuropharmacology; 2021 Jun; 191():108586. PubMed ID: 33940011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
    Sakal C; Lynskey M; Schlag AK; Nutt DJ
    Psychopharmacology (Berl); 2022 May; 239(5):1147-1155. PubMed ID: 33970291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real World Evidence in Medical Cannabis Research.
    Banerjee R; Erridge S; Salazar O; Mangal N; Couch D; Pacchetti B; Sodergren MH
    Ther Innov Regul Sci; 2022 Jan; 56(1):8-14. PubMed ID: 34748204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023.
    Lewis M; Baroutian S; Hanning SM
    Curr Pain Headache Rep; 2024 Mar; 28(3):109-118. PubMed ID: 38095748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
    Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of real world evidence: The case of medical cannabis.
    Schlag AK; Zafar RR; Lynskey MT; Athanasiou-Fragkouli A; Phillips LD; Nutt DJ
    Front Psychiatry; 2022; 13():1027159. PubMed ID: 36405915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
    Friedman D; Sirven JI
    Epilepsy Behav; 2017 May; 70(Pt B):298-301. PubMed ID: 28089286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of cannabidiol trials in neurodevelopmental disorders.
    Parrella NF; Hill AT; Enticott PG; Barhoun P; Bower IS; Ford TC
    Pharmacol Biochem Behav; 2023 Sep; 230():173607. PubMed ID: 37543051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
    Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S
    Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal cannabis for the treatment of anxiety disorders.
    Berger M; Amminger GP; McGregor IS
    Aust J Gen Pract; 2022 Aug; 51(8):586-592. PubMed ID: 35908759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dark Classics in Chemical Neuroscience: Δ
    Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
    ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.